Cargando…
Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia
Acute myeloid leukemia (AML) is a heterogeneous hematopoietic malignancy originated from leukemia stem cells (LSC). Emerging evidence suggests T‐cell immunoglobulin mucin‐3(Tim3) as surface marker for LSC. However, the clinical significance and biology of Tim‐3 in AML remain to be determined, especi...
Autores principales: | Wu, Zhengwei, Ou, Jiawang, Liu, Nannan, Wang, Zhixiang, Chen, Junjie, Cai, Zihong, Liu, Xiaoli, Yu, Xiao, Dai, Min, Zhou, Hongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134367/ https://www.ncbi.nlm.nih.gov/pubmed/36545697 http://dx.doi.org/10.1002/cam4.5549 |
Ejemplares similares
-
Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia
por: Cheng, Zhiheng, et al.
Publicado: (2020) -
Poor Prognosis in Acute Myeloid Leukemia Patients with Monosomal Karyotypes
por: Xu, Junqing, et al.
Publicado: (2017) -
P403: HIGH EXPRESSION OF STAT5 INDICATES POOR PROGNOSIS IN B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
por: Xu, Xiuli, et al.
Publicado: (2023) -
Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion
por: Si, Xiaohui, et al.
Publicado: (2016) -
Identification of Novel Molecular Markers for Prognosis Estimation of Acute Myeloid Leukemia: Over-Expression of PDCD7, FIS1 and Ang2 May Indicate Poor Prognosis in Pretreatment Patients with Acute Myeloid Leukemia
por: Tian, Yiming, et al.
Publicado: (2014)